Carfilzomib: A new opportunity, for WM patients

摘要

WM is a B-cell malignancy characterized by bone marrow infiltration of clonal lymphoplasmacytic cells, which produce a monoclonal immunoglobulin M (IgM). This condition corresponds to the lymphoplasmacytic lymphoma as defined by the World Health Organization classification.